FTC Challenges Grifols/Talecris Merger as Anticompetitive

The Federal Trade Commission will require Grifols, S.A., a manufacturer of plasma-derived drugs, to make significant divestitures as part of a settlement allowing Grifols to acquire a leading plasma-derived drug manufacturer, Talecris Biotherapeutics Holdings Corp. The settlement is the latest FTC action taken to preserve competition and protect U.S. consumers from higher health care costs. […]

Court Halts Bogus Prepaid Calling Card Claims; FTC Alleges Cards Failed to Deliver the Advertised Minutes

At the request of the Federal Trade Commission, a U.S. district court has ordered a temporary halt to the deceptive advertising claims used to promote prepaid phone cards marketed by Millennium Telecard, Inc. The FTC alleges the marketers misrepresent the number of calling minutes their cards deliver and fail to adequately disclose fees that could […]